Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
37.6M
-
Number of holders
-
125
-
Total shares
-
24.1M
-
Shares change
-
+958K
-
Total reported value, excl. options
-
$1.62B
-
Value change
-
+$87.9M
-
Put/Call ratio
-
2.01
-
Number of buys
-
77
-
Number of sells
-
-45
-
Price
-
$67.51
Significant Holders of NEVRO CORP - Common Stock, par value $0.001 per share (NVRO) as of Q4 2015
134 filings reported holding NVRO - NEVRO CORP - Common Stock, par value $0.001 per share as of Q4 2015.
NEVRO CORP - Common Stock, par value $0.001 per share (NVRO) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.1M shares
of 37.6M outstanding shares and own 64% of the company stock.
Largest 10 shareholders include FMR LLC (3.59M shares), ALLIANCEBERNSTEIN L.P. (1.94M shares), SENZAR ASSET MANAGEMENT, LLC (1.68M shares), FRANKLIN RESOURCES INC (1.37M shares), Broadfin Capital, LLC (1.2M shares), VANGUARD GROUP INC (1.13M shares), NEA Management Company, LLC (993K shares), JPMORGAN CHASE & CO (822K shares), LORD, ABBETT & CO. LLC (821K shares), and CITADEL ADVISORS LLC (809K shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.